The human body has an endocannabinoid system — a natural system that maintains homeostasis or balance, in the body. The endocannabinoid system has CB1 and CB2 receptors. These are found throughout the body. CB1 receptors are generally located in the central and peripheral nervous system and CB2 receptors are generally found in the brain, immune system, and gastrointestinal system. CBD binds to these receptors creating changes and effects in the body
Scam CBD sellers tend to manufacture low-grade oils via ethanol (or other solvent-based) extraction, in what is little better than trying to do it yourself in your basement. The result is a liquid that contains a little CBD (along with some other cannabinoids and terpenes), but not in the quantities needed to be effective in terms of any legitimate medicinal function. Moreover, these solvent-based extracts can contain unnecessary and potentially harmful components — after all, scam artists are not going to reveal the REAL ingredients, are they?
The current level of growth in the CBD market is leaving most companies overwhelmed. Poorly run CBD distributors are not set up to provide a high level of service. As a result, many retailers find themselves dealing with delayed orders, missing product, and unreturned phone calls. As you choose a CBD partner, choose a company that has a level of service that leaves you feeling confident.
Endoca’s CBD products are sourced from the highest quality organically grown hemp. From seed to shelf, they oversee their entire US operation and have been awarded by the UN for their sustainable farming and manufacturing processes. In addition to the primary ingredients, this product also includes omega-3, vitamin E and omega-6. There are also low concentrations of essential compounds from the hemp plant. The capsules do not contain any artificial colors, preservatives, GMOs or gluten. They are kosher, gluten-free and vegan.
It’s fair to say that the CBD market is thriving. According to market intelligence company Hemp Business Journal, $130 million worth of products containing the cannabinoid were bought in the U.S. in 2016. And that figure is only set to rise in the years to come, the data analyst believes. Indeed, the source estimates that consumer sales of CBD goods will total an astounding $2.1 billion by 2020 – buoyed, perhaps, by claims that the usage of such products can help alleviate the symptoms of chronic pain, depression and diabetes, to name but a few conditions.
The passing of SB 218 through the Kentucky legislature created a new subsection of KRS 260.850m to 260.289, in which the Industrial Hemp Advisory Board outlines the purpose of an industrial hemp research program, establish license provisions, and create new requirements and license application procedures. This state’s approach is for the potential medical and industrial applications.